FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

2.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

3.

Early-Onset Colorectal Cancer in Male Veterans is Predicted by Risk Factors.

4.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

5.

Measurable Residual Disease Predicts Real-World AML Relapse


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot